Geoffrey is currently a research assistant professor at the University of Michigan Medical School (Department of Internal Medicine) and research associate at the Michigan Center for Global Health Equity. His research focuses on accelerated and equitable innovation using emerging computational technologies such as artificial intelligence, programmable biotechnologies such as CRISPR/Cas systems and frameworks for scientific discovery at a global scale such as open innovation challenges. He is a Co-founder of Anza Biotechnologies, a startup focussed on accelerating discovery and sustainable manufacturing o therapeutics. Previously, he was a research assistant professor at the University of Notre Dame, lead researcher at IBM Research Africa and a co-founder of Helix Nanotechnologies, a DNA nanotechnology company. His work has been featured in several media including CNN, USA Today, Fast Company, Ozy, among other media.